Simply Wall St

At Simply Wall St, we aim to make you a better investor! Our platform provides many useful tools and information to help you research company stocks including: - Detailed company reports - Stock screener and discovery tools - Detailed analysis of your portfolio - A comprehensive dashboard keeping you up to date with companies on your watchlist, and much more! Get started for free by visiting us at https://simplywall.st, and see how we can help you to make better-informed decisions. Follow us on: - Facebook: https://lnkd.in/gqdwVyV - Twitter: https://lnkd.in/gKMuwSy #investing #finance #stocks

Last week’s newsletter was part 1 of an introduction to the financial sector, and specifically banks and companies in the capital markets space. This week we are having a look at the other financial industries, namely insurance, diversified financials, fintech and payments. There has been a notable rise of non-bank lending over the last decade, so we also covered two important implications of this. https://lnkd.in/gwMgd4mx

In last week’s third-quarter review , we mentioned that financial sector stocks are showing signs of life and beginning to outperform. In the era of ‘easy money’, cloud computing, and AI, the financial sector has taken a back seat for a lot of investors. Banks, insurers, and other financial service providers are also very different from most companies, and they can be tricky to understand and analyze. With that in mind, we decided to do a two-part primer on financial sector companies and how they make money. This week we’ll cover banks and companies in the capital markets industry, and next week we’ll look at insurance, diversified financials, payments, and fintech. https://lnkd.in/gveegUgq

Monday marked the end of another quarter, and it’s been an eventful one, too. In fact, we’ve had a bit of everything during the quarter: 🎢 Increased volatility, ✂️ The first US rate cut in years, 🛢️ A collapsing oil price, and 📈Equity indexes trading at new all-time highs. This week we are recapping the major themes from the last three months, and the key insights from earnings season. We are also looking at the way consensus estimates typically evolve over time, and how you can incorporate them when assessing potential investments. https://lnkd.in/gWvjGZ36

Last week, we explored the idea of the US Exceptionalism premium and tried to cover whether or not there was justification for US stocks trading at traditionally higher valuations compared to stocks in other markets. This week, we’re going to look at the flip side of the coin and discuss global diversification, its impact on portfolio performance and whether it's worth implementing in your own portfolio. Traditionally, investors’ portfolios are heavily biased towards stocks from their home country, but we’ll look at ways that investors can gain exposures to new industries and trends that may not be represented in their domestic market. https://lnkd.in/gRV2uUGf

Transform your investing! Our Watchlist 👓 lets you compare fair values from analysts and the community, explore narratives via the Community Hub and project your portfolio's income potential 📊. Plus, we've added new payment options 💳. Check it out now! https://buff.ly/46GUjxM

US market volatility has increased over the last few months, and that has people nervous. There are also several indications that the economy may be entering a recession at a time when US stocks are trading at a premium to many other markets. You might be wondering whether it’s time to switch to other markets, many of which are trading at lower valuations. Hopefully, after this piece, you’ll know what works for you. This week, we are taking a look at the US market’s premium valuation and whether it might be justified, as many believe. Next week, we'll follow up with some thoughts on global diversification. https://lnkd.in/gzCBc-GA

Tesla's much anticipated Robotaxi is scheduled for 10th October. The event has already been pushed out from August, and the fact that it’s now taking place at a film studio in Hollywood only adds to the intrigue and anticipation. The hype around robotaxis is likely to reach fever pitch over the next few weeks, so we thought it would be a good time to look at the opportunity, as well as the potential hurdles and risks facing the companies trying to claim their slice of the market. https://lnkd.in/gVZRi8k9

Last’s week’s Market Insight covered the remarkable growth of GLP-1 diabetes and weight-loss treatments. For now the market is dominated by Novo Nordisk, but at least a dozen other companies are developing and testing similar drugs. This week we are taking a look at some of those companies. We are also highlighting some of the industries and companies that could win or lose if GLP-1 use continues to increase. https://lnkd.in/egQY3XK5

If you’ve been looking for a mega-cap, US listed, reliable dividend payer, Exxon Mobil has probably crossed your desk. Over the last 10 years, it has increased its annual dividend payment by 3.2% per year to $3.80. While its current yield of 3.3% isn’t the highest, it’s above the lowest quartile that only pay 1.4%. The dividend sees affordable, considering it is covered by 45% of its net income and 52% of its cash flow. If analysts forecasts are anything to go by, the annual dividend amount should continue increasing. https://lnkd.in/geW-MPif